AJDRAJNR - American Journal of Neuroradiology

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Barkhof, F.
Right arrow Articles by Nauta, J. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Barkhof, F.
Right arrow Articles by Nauta, J. J.

American Journal of Neuroradiology, Vol 13, Issue 4 1257-1259, Copyright © 1992 by American Society of Neuroradiology


ARTICLES

Gadopentetate dimeglumine enhancement of multiple sclerosis lesions on long TR spin-echo images at 0.6 T

F Barkhof, J Valk, OR Hommes, P Scheltens and JJ Nauta
Department of Diagnostic Radiology, Free University Hospital, Amsterdam, The Netherlands.

The authors sought to determine if Gd-DTPA enhancement of multiple sclerosis (MS) hampers lesion detection on long TR spin-echo images (TE 60 msec) at 0.6 T. They measured the signal intensity (SI) of 41 lesions (10 patients) and normal-appearing gray (NAGM) and white matter (NAWM) before and after administration of contrast. The change in SI of nonenhancing lesions and NAGM and NAWM was small (less than or equal to 1.5%), and of enhancing lesions (5.3%) moderate. The contrast of nonenhancing lesions to NAGM and NAWM changed insignificantly, but the contrast of enhancing lesions to NAGM and NAWM increased significantly. The authors conclude that long TR images can be obtained after Gd-DTPA without hampering lesion conspicuity in research MR protocols in multiple sclerosis.


This article has been cited by other articles:


Home page
NEJMHome page
D. H. Miller, O. A. Khan, W. A. Sheremata, L. D. Blumhardt, G. P.A. Rice, M. A. Libonati, A. J. Willmer-Hulme, C. M. Dalton, K. A. Miszkiel, P. W. O'Connor, et al.
A Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
N. Engl. J. Med., January 2, 2003; 348(1): 15 - 23.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
B. A. t Hart, J. Bauer, H.-J. Muller, B. Melchers, K. Nicolay, H. Brok, R. E. Bontrop, H. Lassmann, and L. Massacesi
Histopathological Characterization of Magnetic Resonance Imaging-Detectable Brain White Matter Lesions in a Primate Model of Multiple Sclerosis : A Correlative Study in the Experimental AutoimmuneEncephalomyelitis Model in Common Marmosets (Callithrixjacchus)
Am. J. Pathol., August 1, 1998; 153(2): 649 - 663.
[Abstract] [Full Text] [PDF]